Navigation Links
Reportlinker Adds Top Ten World's Leading Animal Health Companies
Date:12/17/2009

E MO-5: WORLD ANIMAL HEALTH MARKET BY SPECIES

TABLE MO-6: WORLD ANIMAL HEALTH MARKET FORECAST BY SPECIES

TABLE AL-1: ALPHARMA SALES BY BUSINESS SEGMENT

TABLE AL-2: ALPHARMA OPERATING PROFIT BY BUSINESS SEGMENT

TABLE AL-3: ALPHARMA SALES AND OPERATING PROFIT GROWTH

TABLE AL-4: ALPHARMA SALES BY COUNTRY

TABLE AL-5: ALPHARMA SALES BY PRODUCT LINE

TABLE BA-1: BAYER ANIMAL HEALTH SALES AND OPERATING PROFIT GROWTH

TABLE BA-2: BAYER ANIMAL HEALTH SALES BY GEOGRAPHIC REGION

TABLE BA-3: BAYER ANIMAL HEALTH SALES BY PRODUCT CATEGORY

TABLE BA-4: BAYER ANIMAL HEALTH SALES BY INDIVIDUAL PRODUCT

TABLE EL-1: ELI LILLY/ELANCO SALES BY BUSINESS SEGMENT

TABLE EL-2: ELI LILLY/ELANCO SALES GROWTH BY BUSINESS SEGMENT

TABLE EL-3: ELI LILLY/ELANCO ANIMAL HEALTH SALES BY GEOGRAPHIC

REGION

TABLE ME-1: MERIAL SALES AND OPERATING PROFIT GROWTH

TABLE ME-2: MERIAL SALES BY PRODUCT LINE

TABLE ME-3: MERIAL SALES GROWTH BY PRODUCT LINE

TABLE NO-1: NOVARTIS ANIMAL HEALTH SALES AND OPERATING PROFIT

GROWTH

TABLE NO-1: NOVARTIS SALES AND OPERATING PROFIT GROWTH

TABLE NO-2: NOVARTIS SALES BY BUSINESS SEGMENT

TABLE NO-3: NOVARTIS SALES GROWTH BY BUSINESS SEGMENT

TABLE NO-4: NOVARTIS OPERATING PROFIT BY BUSINESS SEGMENT

TABLE NO-5: NOVARTIS OPERATING PROFIT GROWTH BY BUSINESS SEGMENT

TABLE NO-6: NOVARTIS SALES BY COUNTRY

TABLE NO-7: NOVARTIS SALES GROWTH BY COUNTRY

TABLE NO-8: NOVARTIS SALES BY THERAPEUTIC CATEGORY

TABLE NO-9: NOVARTIS SALES GROWTH BY THERAPEUTIC CATEGORY

TABLE NO-10: NOVARTI
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
2. Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
3. Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
4. Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
5. Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)
7. Reportlinker Adds Japanese Market for Dental Implants and Final Abutments 2009
8. Reportlinker Adds Japanese Market for Womens Health Devices 2009
9. Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)
10. Reportlinker Adds Mesenchymal Stem Cells, Advances & Applications
11. Reportlinker Adds Sterilization Technologies: The U.S. Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
(Date:1/22/2015)... 2015 EBSCO Information Services (EBSCO) ... their relationship in an effort to further promote visibility and ... EBSCO has long made AMA journals available via its subscription ... The JAMA Network. , Long known as both ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Up Call as Lighthouse International and EHE International unveil a ... of New Yorkers will see a new warning sign in ... their vision. The sign, located at 10 Rockefeller Plaza and ... a l03-year-old leader in vision healthcare. It will be on ...
... Over 80 percent of Americans suffer from ... their skin, but their self esteem as well. Many reach ... in cosmetic products in the European Union and the desire ... are taking a hard look at their acne treatments and ...
... session in Orlando, FL will feature strategies and tools that increase ... ... Orlando, FL (Vocus) January 8, 2009 -- Facing unprecedented marketplace disruption ... consumer autonomy in health insurance selection - the retention of individual ...
... NEW ROCHELLE, N.Y., Jan. 8 Natural gas, believed to ... airborne particulate matter when burned in home appliances such as ... the December 2008 issue (Volume 25, Number 10) of ... Mary Ann Liebert, Inc. The paper ...
... and the University of Barcelona have shown that treatment ... pomace, results in a significant inhibition of cell proliferation ... is a novel natural compound and it is able ... colon-cancer cells via the intrinsic mitochondrial pathway. Scientifics suggest ...
... safety advocates to launch congressional campaign to prod all ... 40,000 deaths and $230 billion in economic losses.***Free Webcast ... Conference***WASHINGTON, Jan. 8 The following was issued by ... As state legislatures across the nation gear up for ...
Cached Medicine News:Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 2Health News:61 Million Americans are at Risk of Vision Loss and Don't Even Know It 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 2Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 3Health News:World Health Care Congress and Connextions Health Will Host Leadership Summit to Address Member Retention for Health Insurance Plans 4Health News:Particulate Emission from Natural Gas Burning Home Appliances Is Assessed in Environmental Engineering Science Journal 2Health News:Each State to Receive Report Card Grading Their Progress in Passing Model Traffic Safety Laws 2
(Date:1/23/2015)... SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, ... where its Phase I trial of Lixte,s lead compound, LB‑100, ... institutions. John S. Kovach , M.D., the ... was planned to be completed at a single site. Accrual ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... with investigators worldwide to develop new treatments for ... diverse forms of cancer - Plenary ... of patients with early-stage breast cancer, - Four oral sessions to feature ... study in renal cell ...
... Hispanics/Latinos, People ... with Diabetes and Obese Individuals, PARSIPPANY, N.J., ... presented at the American Society of,Hypertension,s Twenty- Third Annual ... powerful combination drug AZOR(TM),(amlodipine and olmesartan medoxomil) safely and ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7
... The BioPlex 2200 system is ... platform that can deliver up to ... will initially include a panel of ... in development are in the areas ...
... and a FAM-labeled probe that is designed to ... gene. In addition, the B. pertussis ASR contains ... an internal control sequence. This ASR requires an ... reporter dyes such as the Cepheid SmartCycler System. ...
... The Stratus CS Analyzer, designed for Acute Care ... your laboratory and near patient setting. It's a ... or D-Dimer results from a whole blood sample ... 3 step process load sample and rotor, ...
... The CritSpin whisper quiet, compact system is ... anywhere fast, accurate and cost effective microhematocrits ... Reader, the CritSpin System offers a range ... complete cell packing - Meets NCCLS standards ...
Medicine Products: